Moderate

Typical atrial flutter — chronic management & ablation

Cavotricuspid isthmus flutter · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Typical atrial flutter is a macro-re-entrant atrial tachycardia around the cavotricuspid isthmus producing sawtooth flutter waves, commonly at an atrial rate near 300 bpm with 2:1 conduction. Cavotricuspid isthmus ablation is highly effective and first-line for durable cure.

Red flags

  • 1:1 atrioventricular conduction (very fast, unstable)
  • Haemodynamic instability
  • Flutter with pre-excitation
  • Syncope
  • Rate uncontrollable with medication

Assessment

Differential diagnosis

  • Atrial fibrillation
  • Atypical (left atrial) flutter
  • Focal atrial tachycardia
  • Sinus tachycardia
  • AVNRT
  • Multifocal atrial tachycardia

Investigations

  • 12-lead ECG (negative sawtooth flutter waves in inferior leads)
  • TTE for atrial size and LV function
  • TSH, electrolytes
  • Ambulatory monitor if paroxysmal
  • Renal function to guide anticoagulation dosing
  • Transoesophageal echo before cardioversion if not anticoagulated

Management

  • Confirm typical flutter and estimate the conduction ratio
  • Apply the same stroke-risk approach as AF: CHA2DS2-VASc and anticoagulation
  • Start a DOAC unless contraindicated
  • Achieve rate control with a beta-blocker or non-dihydropyridine CCB (often difficult)
  • Arrange cardioversion (electrical or with ibutilide) with appropriate anticoagulation cover
  • Refer for cavotricuspid isthmus ablation as first-line definitive therapy
  • Screen for and manage co-existent atrial fibrillation
  • Treat reversible triggers (thyroid disease, lung disease, alcohol)
  • Continue anticoagulation after ablation based on stroke risk, not rhythm outcome
  • Counsel that AF may still occur after successful flutter ablation
  • Monitor for recurrence with ambulatory ECG
  • Arrange electrophysiology follow-up

Drugs & doses

Apixaban 5 mg PO BD (dose-reduce per criteria) or alternative DOAC
Bisoprolol 2.5-10 mg PO OD for rate control
Diltiazem SR 180-360 mg PO daily if beta-blocker unsuitable
Ibutilide 1 mg IV over 10 min (pharmacological cardioversion, monitored)
Flecainide 50-150 mg PO BD only with AV-nodal blocker to prevent 1:1 conduction

Disposition

Electrophysiology referral for ablation; GP/cardiology for anticoagulation and rate control. Admit for 1:1 conduction or instability.

Complications & pitfalls

  • Thromboembolic stroke
  • Tachycardia-mediated cardiomyopathy
  • 1:1 conduction if class Ic given without AV blockade
  • Progression to atrial fibrillation
  • Recurrence after ablation (low for typical flutter)

Exam pearls

  • Rate control is often harder to achieve in flutter than in AF — favour rhythm control/ablation
  • Cavotricuspid isthmus ablation has >90% long-term success for typical flutter
  • Anticoagulation decisions mirror atrial fibrillation
  • Never give flecainide alone — slowing the atrial rate can allow 1:1 AV conduction
  • AF commonly coexists or follows, so continued monitoring is essential

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.